Practice Mobile Menu Trigger Overview Experience Team Insights Subscribe to insights October 11, 2021 Articles & Books Lexology Getting the Deal Through: Private M&A 2022 Davis Polk partners Will Pearce and Louis Goldberg are delighted to be contributing editors of the updated edition of Lexo... August 27, 2021 Client Update Law firm response to Investment Company Act lawsuits targeting the SPAC industry Updated September 3, 2021Recently a purported shareholder of certain SPACs initiated derivative lawsuits asserting that th... August 25, 2021 Articles & Books Identifying Item 4(c) and 4(d) Documents: Updates to a Classic Davis Polk counsel Mary Marks, associate Gregory Morrison and law clerk Elena Joffroy recently authored “Identifying Ite... August 5, 2021 Client Update FTC to issue “Warning Letters” that deals remain subject to antitrust review post-closing The Federal Trade Commission has announced that a “tidal wave” of HSR filings has strained its capacity to review merg... July 15, 2021 Client Update SEC charges SPAC, sponsor, target and CEOs for misleading disclosures and inadequate due diligence The SEC continued its recent focus on SPACs by filing charges against both sides of a planned but not yet completed SPAC m... April 12, 2021 Client Update New NYSE rules ease shareholder approval requirements, but may expand audit committee role On April 2nd, the SEC approved NYSE rule changes that will relax current requirements to obtain shareholder approval prior... April 1, 2021 Client Update Antitrust enforcement in 2021 and beyond: Insights from the ABA’s Antitrust Spring Meeting On March 23-26, 2021, the American Bar Association’s Section of Antitrust Law held its annual Spring Meeting virtually. ... April 1, 2021 Client Update European Commission amends referral policy to allow review of previously non-reportable ‘killer acquisitions’ On 26 March 2021, the European Commission published new guidance on when it will accept referrals from EU National Competi... March 17, 2021 Client Update U.S., EU, U.K., and other antitrust enforcers enter collaboration on antitrust analysis of pharma deals On March 16, 2021, a coalition of international and U.S. antitrust authorities announced their formation of a joint workin... March 3, 2021 Client Update UK listing review publishes recommendations On 3 March 2021, the review of the UK listing regime chaired by Lord Jonathan Hill published its recommendations to the Ch... Load More
October 11, 2021 Articles & Books Lexology Getting the Deal Through: Private M&A 2022 Davis Polk partners Will Pearce and Louis Goldberg are delighted to be contributing editors of the updated edition of Lexo...
August 27, 2021 Client Update Law firm response to Investment Company Act lawsuits targeting the SPAC industry Updated September 3, 2021Recently a purported shareholder of certain SPACs initiated derivative lawsuits asserting that th...
August 25, 2021 Articles & Books Identifying Item 4(c) and 4(d) Documents: Updates to a Classic Davis Polk counsel Mary Marks, associate Gregory Morrison and law clerk Elena Joffroy recently authored “Identifying Ite...
August 5, 2021 Client Update FTC to issue “Warning Letters” that deals remain subject to antitrust review post-closing The Federal Trade Commission has announced that a “tidal wave” of HSR filings has strained its capacity to review merg...
July 15, 2021 Client Update SEC charges SPAC, sponsor, target and CEOs for misleading disclosures and inadequate due diligence The SEC continued its recent focus on SPACs by filing charges against both sides of a planned but not yet completed SPAC m...
April 12, 2021 Client Update New NYSE rules ease shareholder approval requirements, but may expand audit committee role On April 2nd, the SEC approved NYSE rule changes that will relax current requirements to obtain shareholder approval prior...
April 1, 2021 Client Update Antitrust enforcement in 2021 and beyond: Insights from the ABA’s Antitrust Spring Meeting On March 23-26, 2021, the American Bar Association’s Section of Antitrust Law held its annual Spring Meeting virtually. ...
April 1, 2021 Client Update European Commission amends referral policy to allow review of previously non-reportable ‘killer acquisitions’ On 26 March 2021, the European Commission published new guidance on when it will accept referrals from EU National Competi...
March 17, 2021 Client Update U.S., EU, U.K., and other antitrust enforcers enter collaboration on antitrust analysis of pharma deals On March 16, 2021, a coalition of international and U.S. antitrust authorities announced their formation of a joint workin...
March 3, 2021 Client Update UK listing review publishes recommendations On 3 March 2021, the review of the UK listing regime chaired by Lord Jonathan Hill published its recommendations to the Ch...